54
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Protein quality control in the secretory pathway

      review-article
      ,
      The Journal of Cell Biology
      Rockefeller University Press

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          One third of the eukaryotic proteome matures in the secretory pathway. Sun and Brodsky describe the machinery that maintains protein fidelity and how its actions are coordinated.

          Abstract

          Protein folding is inherently error prone, especially in the endoplasmic reticulum (ER). Even with an elaborate network of molecular chaperones and protein folding facilitators, misfolding can occur quite frequently. To maintain protein homeostasis, eukaryotes have evolved a series of protein quality-control checkpoints. When secretory pathway quality-control pathways fail, stress response pathways, such as the unfolded protein response (UPR), are induced. In addition, the ER, which is the initial hub of protein biogenesis in the secretory pathway, triages misfolded proteins by delivering substrates to the proteasome or to the lysosome/vacuole through ER-associated degradation (ERAD) or ER-phagy. Some misfolded proteins escape the ER and are instead selected for Golgi quality control. These substrates are targeted for degradation after retrieval to the ER or delivery to the lysosome/vacuole. Here, we discuss how these guardian pathways function, how their activities intersect upon induction of the UPR, and how decisions are made to dispose of misfolded proteins in the secretory pathway.

          Related collections

          Most cited references208

          • Record: found
          • Abstract: found
          • Article: not found

          Physiological functions of the HECT family of ubiquitin ligases.

          The ubiquitylation of proteins is carried out by E1, E2 and E3 (ubiquitin ligase) enzymes, and targets them for degradation or for other cellular fates. The HECT enzymes, including Nedd4 family members, are a major group of E3 enzymes that dictate the specificity of ubiquitylation. In addition to ubiquitylating proteins for degradation by the 26S proteasome, HECT E3 enzymes regulate the trafficking of many receptors, channels, transporters and viral proteins. The physiological functions of the yeast HECT E3 ligase Rsp5 are the best known, but the functions of HECT E3 enyzmes in metazoans are now becoming clearer from in vivo studies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            ER-associated degradation: Protein quality control and beyond

            Even with the assistance of many cellular factors, a significant fraction of newly synthesized proteins ends up misfolded. Cells evolved protein quality control systems to ensure that these potentially toxic species are detected and eliminated. The best characterized of these pathways, the ER-associated protein degradation (ERAD), monitors the folding of membrane and secretory proteins whose biogenesis takes place in the endoplasmic reticulum (ER). There is also increasing evidence that ERAD controls other ER-related functions through regulated degradation of certain folded ER proteins, further highlighting the role of ERAD in cellular homeostasis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates

              Summary The two main routes that cells use for degrading intracellular proteins are the ubiquitin-proteasome and autophagy-lysosome pathways, which have been thought to have largely distinct clients. Here, we show that autophagy inhibition increases levels of proteasome substrates. This is largely due to p62 (also called A170/SQSTM1) accumulation after autophagy inhibition. Excess p62 inhibits the clearance of ubiquitinated proteins destined for proteasomal degradation by delaying their delivery to the proteasome's proteases. Our data show that autophagy inhibition, which was previously believed to only affect long-lived proteins, will also compromise the ubiquitin-proteasome system. This will lead to increased levels of short-lived regulatory proteins, like p53, as well as the accumulation of aggregation-prone proteins, with predicted deleterious consequences.
                Bookmark

                Author and article information

                Journal
                J Cell Biol
                J. Cell Biol
                jcb
                jcb
                The Journal of Cell Biology
                Rockefeller University Press
                0021-9525
                1540-8140
                07 October 2019
                19 September 2019
                : 218
                : 10
                : 3171-3187
                Affiliations
                [1]Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA
                Author notes
                Correspondence to Jeffrey L. Brodsky : jbrodsky@ 123456pitt.edu
                Author information
                https://orcid.org/0000-0001-5753-6680
                https://orcid.org/0000-0002-6984-8486
                Article
                201906047
                10.1083/jcb.201906047
                6781448
                31537714
                1e93af78-c6b5-43a2-bda7-7c66322a37ad
                © 2019 Sun and Brodsky

                This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).

                History
                : 07 June 2019
                : 22 July 2019
                : 29 August 2019
                Page count
                Pages: 17
                Funding
                Funded by: National Institutes of Health, DOI https://doi.org/10.13039/100000002;
                Award ID: R01 GM075061
                Award ID: P30 DK079307
                Award ID: R35 GM131732
                Categories
                Reviews
                Review

                Cell biology
                Cell biology

                Comments

                Comment on this article